Home Parenteral Nutrition: Fat Emulsions and Potential Complications

被引:27
作者
Mundi, Manpreet S. [1 ]
Salonen, Bradley R. [2 ]
Bonnes, Sara [2 ]
机构
[1] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA
关键词
parenteral nutrition; home nutrition support; lipids; intravenous fat emulsions; MEDIUM-CHAIN TRIGLYCERIDES; RETICULOENDOTHELIAL SYSTEM FUNCTION; INTRAVENOUS LIPID EMULSIONS; TOTAL NUTRIENT ADMIXTURES; ACID DEFICIENCY; LIVER-DISEASE; FISH-OIL; LONG-CHAIN; INTESTINAL FAILURE; DOUBLE-BLIND;
D O I
10.1177/0884533616663635
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Since the first intravenous nutrition support attempt with olive oil in the 17th century, intravenous fat emulsions (IVFEs) have evolved to become an integral component in the management of patients receiving home parenteral nutrition (HPN). IVFEs serve as a calorie source and provide essential fatty acids (linoleic acid and -linolenic acid) in patients unable to achieve adequate intake of these fatty acids through alternative means. However, IVFE use is also associated with multiple complications, including increased infection risk, liver disease, and systemic proinflammatory states. In the United States, most IVFEs are composed of 100% soybean oil; internationally multiple alternative IVFEs (using fish oil, olive oil, and long- and medium-chain triglycerides) are available or being developed. The hope is that these IVFEs will prevent, or decrease the risk of, some of the HPN-associated complications. The goal of this article is to review how IVFEs came into use, their composition and metabolism, options for IVFE delivery in HPN, benefits and risks of IVFE use, and strategies to minimize the risks associated with IVFE use in HPN patients.
引用
收藏
页码:629 / 641
页数:13
相关论文
共 127 条
[1]  
A. S. P. E. N. Board of Directors and Task Force on Parenteral Nutrition Standardization, 2007, JPEN J PARENTER ENTE, V31, P441
[2]  
Alfonso JE, 2016, JPEN J PARENTER ENTE
[3]   ASPEN Parenteral Nutrition Safety Consensus Recommendations Translation Into Practice [J].
Ayers, Phil ;
Adams, Stephen ;
Boullata, Joseph ;
Gervasio, Jane ;
Holcombe, Beverly ;
Kraft, Michael D. ;
Marshall, Neil ;
Neal, Antoinette ;
Sacks, Gordon ;
Seres, David S. ;
Worthington, Patricia ;
Guenter, Peggi .
NUTRITION IN CLINICAL PRACTICE, 2014, 29 (03) :277-282
[4]   MEDIUM-CHAIN TRIGLYCERIDES - AN UPDATE [J].
BACH, AC ;
BABAYAN, VK .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1982, 36 (05) :950-962
[5]   Influence of Lipid Type on Bis (2-ethylhexyl)phthalate (DEHP) Leaching From Infusion Line Sets in Parenteral Nutrition [J].
Bagel, Sandrine ;
Dessaigne, Berangere ;
Bourdeaux, Daniel ;
Boyer, Anne ;
Bouteloup, Corinne ;
Bazin, Jean-Etienne ;
Chopineau, Jean ;
Sautou, Valerie .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2011, 35 (06) :770-775
[6]  
Barbier J, 1992, Chirurgie, V118, P47
[7]   ALPHA-TOCOPHEROL DEFICIENCY FAILS TO AGGRAVATE TOXIC LIVER-INJURY BUT LIVER-INJURY CAUSES ALPHA-TOCOPHEROL RETENTION [J].
BARROW, L ;
PATEL, HR ;
TANNER, MS .
JOURNAL OF HEPATOLOGY, 1992, 16 (03) :332-337
[8]   IS URSODEOXYCHOLIC ACID AN EFFECTIVE THERAPY FOR TOTAL PARENTERAL NUTRITION-RELATED LIVER-DISEASE [J].
BEAU, P ;
LABATLABOURDETTE, J ;
INGRAND, P ;
BEAUCHANT, M .
JOURNAL OF HEPATOLOGY, 1994, 20 (02) :240-244
[9]   Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease [J].
Bharadwaj, Shishira ;
Gohel, Tushar ;
Deen, Omer J. ;
DeChicco, Robert ;
Shatnawei, Abdullah .
GASTROENTEROLOGY REPORT, 2015, 3 (02) :110-114
[10]   Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads lecture [J].
Bistrian, BR .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2003, 27 (03) :168-175